METHYLENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methylene, and when can generic versions of Methylene launch?
Methylene is a drug marketed by Chengdu Shuode, Hikma, Meitheal, Nexus, Steriscience, Xiromed, and Zydus Lifesciences. and is included in seven NDAs.
The generic ingredient in METHYLENE is methylene blue. There are twenty-five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylene blue profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylene
A generic version of METHYLENE was approved as methylene blue by ZYDUS LIFESCIENCES on December 5th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHYLENE?
- What are the global sales for METHYLENE?
- What is Average Wholesale Price for METHYLENE?
Summary for METHYLENE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for METHYLENE |
| DailyMed Link: | METHYLENE at DailyMed |
US Patents and Regulatory Information for METHYLENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chengdu Shuode | METHYLENE BLUE | methylene blue | SOLUTION;INTRAVENOUS | 219550-001 | Dec 23, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | METHYLENE BLUE | methylene blue | SOLUTION;INTRAVENOUS | 215636-003 | Feb 2, 2026 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nexus | METHYLENE BLUE | methylene blue | SOLUTION;INTRAVENOUS | 217561-001 | Nov 21, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | METHYLENE BLUE | methylene blue | SOLUTION;INTRAVENOUS | 215636-001 | Dec 5, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
